Alixia
Targeting the Tumor Ecosystem to address cancer drug resistance.
Biotech
Therapeutics
Drug discovery
Oncology
Biotechnology
About
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.
Details
Status
Active
Stage
Early
Team Size
2
Regions
United States of America, America / Canada